GlassScriptPhysician profile
Ilana Etelzon
NPI 1730471814
$5,021.61
in general payments reported to CMS, 2019-2025
24 companies · $179 in 2025
The $179 reported for 2025 was more than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $523 · 2021: $1,129 · 2022: $877 · 2023: $1,997 · 2024: $317 · 2025: $179.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,382 · Travel and Lodging: $1,110.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,382.46 |
| Travel and Lodging | $1,109.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,447.82 | 2021-2024 | Venaseal, Intellis Adaptivestim |
| Nevro Corp. | $1,295.40 | 2021-2024 | Senza, Vyrsa V1 |
| Abbvie INC. | $414.68 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $319.03 | 2020-2021 | |
| Bard Peripheral Vascular, INC. | $283.55 | 2023 | Venclose Maven Catheter |
| Medtronic USA, INC. | $206.84 | 2020 | |
| Horizon Therapeutics Plc | $160.76 | 2020-2022 | |
| Spr Therapeutics, INC | $132.89 | 2022-2023 | Sprint Pns System |
| Bioness INC | $131.36 | 2020 | |
| Nuvasive, INC. | $99.94 | 2022 | |
| Scilex Pharmaceuticals INC. | $91.77 | 2020-2022 | |
| Globus Medical, INC. | $84.53 | 2025 | Senza |
| Painteq LLC | $52.50 | 2021 | |
| Forte Bio-Pharma LLC | $51.66 | 2024-2025 | Prolate, Nalocet, Tanlor |
| Nalu Medical, INC. | $48.94 | 2025 | Nalu Neurostimulation System |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $36.38 | 2021 | |
| Si-Bone, INC. | $29.55 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $27.68 | 2022 | |
| Allergan, INC. | $22.75 | 2022 | |
| Pacira Therapeutics, INC. | $20.34 | 2020 | |
| Zyla Life Sciences, INC. | $18.27 | 2020 | |
| Curonix LLC | $15.92 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Abbott Laboratories | $15.90 | 2021 | |
| Lilly USA, LLC | $13.15 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ilana Etelzon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.